Janux Therapeutics, Inc. (JANX)
13.08
-0.34
(-2.53%)
USD |
NASDAQ |
Feb 20, 16:00
13.10
+0.02
(+0.11%)
After-Hours: 20:00
Janux Therapeutics SG&A Expense (Quarterly) : 10.62M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 2.181B |
| Eli Lilly & Co. | 3.132B |
| Ionis Pharmaceuticals, Inc. | 96.81M |
| MannKind Corp. | 58.18M |
| EyePoint Plc | 14.52M |